EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Clinical Characteristics, Diagnosis and Short-Term Outcomes of COVID-19–Associated Acute Myocarditis in China

Huihui Liu, Ping Zhou iD, Yan Huang, Sulan Yan, Lei Zhou, Chuanyu Gao, Lian Wang, Jianjun Tang, Qiong Zhou, Xinqing Li, Xiaofeng Zhuang, Mei Zhai und 6 weitere

ESC Heart Failure · 2025

DOI: 10.1002/ehf2.15048 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Huihui Liu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of…. Hauptthemen laut MEDLINE: COVID-19, Myocarditis, SARS-CoV-2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Acute myocarditis (AM) has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) infection. This study was conducted to present the clinical characteristics, disease courses and short-term prognoses of Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induced AM in China, which has been unavailable so far. Methods and results Data from 28 patients diagnosed with definite COVID-19–associated AM from 6 hospitals in China between 1 December 2022 and 30 June 2023 were collected and analysed. The diagnosis of AM was based on increased troponin level plus typical findings of AM on cardiac magnetic resonance (CMR) imaging and/or endomyocardial biopsy. Among 28 patients with definite COVID-19–related AM, median age was 37 years (Q1–Q3: 22–52) and 53.6% were men. Twenty-three patients occurred within 2 weeks of the onset of COVID-19 infection, 10 patients underwent endomyocardial biopsy and CMR was performed in all patients. Seven (25.0%) patients developed fulminant myocarditis that required inotropic agents or temporary mechanical circulatory support. Of the nine patients (32.1%) with left ventricular ejection fraction (LVEF) below 50% on admission, five had fully recovered LVEF and two demonstrated improvement but to levels below normal at discharge. The comparison of CMR parameters between the baseline and first follow-up showed that ECV was decreased at the first follow-up [28.95 (25.38, 32.55)% vs. 33.65 (31.58, 37.55)%, P = 0.028), while other CMR parameters had no significant changes. Eighteen patients (64.3%) were prescribed with corticosteroids, and seven patients (25.0%) underwent temporary mechanical circulatory support. Only two patients died during hospitalization.

Conclusions

The majority of COVID-19–associated AM occurred within 2 weeks of Omicron variant infection. Fulminant myocarditis complicated by hemodynamic instability requiring temporary mechanical circulatory support was not uncommon. However, short-term outcome was generally good and most AM patients fully recovered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MyocarditisSARS-CoV-2HumansMaleFemaleChinaAdultMiddle AgedAcute DiseaseYoung AdultMagnetic Resonance Imaging, CineRetrospective StudiesPrognosisStroke Volume

Stichwörter der Autor:innen

COVID‐19MyocarditisOutcomeSARS‐CoV‐2

Autor:innen und Institutionen

  • Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Cardiology, The People's Hospital of Hunan Province, Changsha, China.
  • Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Cardiology, Heart Center of Henan Provincial People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Cardiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.

ORCID-Profile: Ping Zhou

Förderung

  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Liu, H., Zhou, P., Huang, Y., Yan, S., Zhou, L., Gao, C., Wang, L., Tang, J., Zhou, Q., Li, X., Zhuang, X., Zhai, M., Huang, L., Zhao, X., Greenberg, B., Hsi, D. H., Zhang, Y., & Zhang, J. (2025). Clinical Characteristics, Diagnosis and Short-Term Outcomes of COVID-19–Associated Acute Myocarditis in China. ESC Heart Failure. https://doi.org/10.1002/ehf2.15048

Vancouver

Liu H, Zhou P, Huang Y, Yan S, Zhou L, Gao C, et al. Clinical Characteristics, Diagnosis and Short-Term Outcomes of COVID-19–Associated Acute Myocarditis in China. ESC Heart Failure. 2025. doi:10.1002/ehf2.15048

BibTeX
@article{Liu2025,
  author = {Liu, Huihui and Zhou, Ping and Huang, Yan and Yan, Sulan and Zhou, Lei and Gao, Chuanyu and Wang, Lian and Tang, Jianjun and Zhou, Qiong and Li, Xinqing and Zhuang, Xiaofeng and Zhai, Mei and Huang, Liyan and Zhao, Xuemei and Greenberg, Barry and Hsi, David H and Zhang, Yuhui and Zhang, Jian},
  title = {Clinical Characteristics, Diagnosis and Short-Term Outcomes of COVID-19–Associated Acute Myocarditis in China},
  journal = {ESC Heart Failure},
  year = {2025},
  doi = {10.1002/ehf2.15048}
}
Kostenlos starten →